Bank Of America Corp Avidity Biosciences, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 191,271 shares of RNA stock, worth $9.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

191,271

Previous 181,671 5.28%

Holding current value

$9.04 Million

Previous $4.64 Million 68.53%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.73 - $40.85 $218,208 - $392,160	9,600 Added 5.28%	191,271 $7.81 Million
Q1 2024 May 15, 2024	SELL	$9.16 - $25.52 $723,062 - $2.01 Million	-78,937 Reduced 30.29%	181,671 $4.64 Million
Q4 2023 Feb 14, 2024	SELL	$4.87 - $9.37 $2.07 Million - $3.99 Million	-425,917 Reduced 62.04%	260,608 $2.36 Million
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $2.97 Million - $4.86 Million	280,031 Added 68.89%	686,525 $7.61 Million
Q1 2023 May 12, 2023	BUY	$15.35 - $25.65 $2.49 Million - $4.16 Million	162,134 Added 66.35%	406,494 $6.24 Million
Q4 2022 Feb 10, 2023	BUY	$10.06 - $22.66 $1.77 Million - $3.98 Million	175,770 Added 256.26%	244,360 $5.42 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $217,831 - $330,128	14,090 Added 25.85%	68,590 $1.12 Million
Q2 2022 Aug 12, 2022	BUY	$11.18 - $20.5 $132,438 - $242,843	11,846 Added 27.77%	54,500 $791,000
Q1 2022 May 16, 2022	SELL	$14.2 - $23.78 $659,618 - $1.1 Million	-46,452 Reduced 52.13%	42,654 $788,000
Q4 2021 Feb 08, 2022	BUY	$20.4 - $28.66 $1.35 Million - $1.9 Million	66,322 Added 291.09%	89,106 $2.12 Million
Q3 2021 Nov 15, 2021	SELL	$18.16 - $25.21 $164,892 - $228,906	-9,080 Reduced 28.5%	22,784 $562,000
Q2 2021 Sep 13, 2021	BUY	$19.62 - $29.26 $625,171 - $932,340	31,864 New	31,864 $788,000

Others Institutions Holding RNA

# of Institutions

221

Shares Held

95.9M

Call Options Held

171K

Put Options Held

196K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.46B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Avidity Biosciences, Inc. Transaction History